Page 316 - Read Online
P. 316

Page 10 of 11                                         Kumar et al. Plast Aesthet Res 2020;7:29  I  http://dx.doi.org/10.20517/2347-9264.2019.71

               Availability of data and materials
               Not applicable.


               Financial support and sponsorship
               None.


               Conflicts of interest
               All authors declared that there are no conflicts of interest.


               Ethical approval and consent to participate
               Not applicable.

               Consent for publication
               Not applicable.


               Copyright
               © The Author(s) 2020.

               REFERENCES
               1.   Bogens RB, Liu-Snyder P. Understanding Secondary Injury. Q Rev Biol 2012;87:89-127.
               2.   Merrick MA. Secondary injury after musculoskeletal trauma: a review and update. J Athl Train 2002;37:209-17.
               3.   Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, et al. Definitions for sepsis and organ failure and guidelines for the use of
                   innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of
                   Critical Care Medicine. Chest 1992;101:1644-55.
               4.   Knight KL. Cryotherapy in Sports Injury Management. Human Kinetics Chamain, IL: 1995. pp. 3-98
               5.   Banasik JL. Cell inury, aging and death. In: Costead LC, Banasik JL, editors. Pathophysiology: Biological and Behaorial Perspectives.
                   2nd ed. WB Saundrs Philadelhia, PA: 2000. pp. 76-91.
               6.   Kougias P, Chai H, Lin PH, Yao Q, Lumsden AB, et al. Defensins and cathelicidins: neutrophil peptides with roles in inflammation,
                   hyperlipidemia and atherosclerosis. J Cell Mol Med 2005;9:3-10.
               7.   Belkin M, Brown RD, Wright JG, LaMorte WW, Hobson RW. A new quantitative spectrophotometric assay of ischemia-reperfusion
                   injury in skeletal muscle. Am J Surg 1988;156:83-6.
               8.   Serrano-Puebla A, Boya P. Lysosomal membrane permeabilization in cell death: new evidence and implications for health and disease.
                   Ann N Y Acad Sci 2016;1371:30-44.
               9.   Aits S, Jäättelä M. Lysosomal cell death at a glance. J Cell Sci 2013;126:1905-12.
               10.  Starke PE, Hoek JB, Farber JL. Calcium-dependent and calcium-independent mechanisms of irreversible cell injury in cultured
                   hepatocytes. J Biol Chem 1986;261:3006-12.
               11.  Manjo G, Joris I. Cells, tissues, and disease: principles of general pathology. Blackwell Scientific; Cambridge, MA: 1996.
               12.  Kim SO, Baines CP, Critz SD, Pelech SL, Katz S, et al. Ischemia induced activation of heat shock protein 27 kinases and casein kinase 2
                   in the preconditioned rabbit heart. Biochem Cell Biol 1999;77:559-67.
               13.  Sabido F, Milazzo VJ, Hobson RW, Duran WN. Skeletal muscle ischemia-reperfusion injury: a review of endothelial cell-leukocyte
                   interactions. J Invest Surg 1994;7:39-47.
               14.  Bernardi P. Mitochondria in muscle cell death. Ital J Neurol Sci 1999;20:395-400.
               15.  Rizzuto R, Bernardi, Pozzan T. Mitochondria as all round players of the calcium game. J Physiol 2000;529:37-47.
               16.  Kirkman E, Watts S. Haemodynamic changes in trauma. Br J Anaesth 2014;113:266-75.
               17.  Fish R. Electric shock, Part II: nature and mechanisms of injury. J Emerg Med 1993;11:457-62.
               18.  Lee RC. Injury by electrical forces: pathophysiology, manifestations, and therapy. Curr Probl Surg 1997;34:677-764.
               19.  Jaffer U, Wade RG, Gourlay T. Cytokines in the systemic inflammatory response syndrome: a review. HSR Proc Intensive Care
                   Cardiovasc Anesth 2010;2:161-75.
               20.  Socha LA, Gowardman J, Silva D, Correcha M, Petrosky N. Elevation in interleukin 13 levels in patients diagnosed with systemic
                   inflammatory response syndrome. Intensive Care Med 2006;32:244-50.
               21.  Zhang JM, An J. Cytokines, inflammation, and pain. Int Anesthesiol Clin 2007;45:27-37.
               22.  Bates P, Parker P, McFadyen I, Pallister I. Demystifying damage control in musculoskeletal trauma. Ann R Coll Surg Engl 2016;98:291-4.
               23.  Aikawa N. Cytokine storm in the pathogenesis of multiple organ dysfunction syndrome associated with surgical insults. Nihon Geka
                   Gakkai Zasshi 1996;97:771-7. (in Japanese)
               24.  Chousterman BG, Swirski FK, Weber GF. Cytokine storm and sepsis disease pathogenesis. Semin Immunopathol 2017;39:517-28.
               25.  Kumar P. Wheel of death: cytokine cascade (cytokine storm) in cases with extensive wound. JSWCR 2013;6:1-2.
   311   312   313   314   315   316   317   318   319   320   321